[go: up one dir, main page]

NO20055774D0 - Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere - Google Patents

Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere

Info

Publication number
NO20055774D0
NO20055774D0 NO20055774A NO20055774A NO20055774D0 NO 20055774 D0 NO20055774 D0 NO 20055774D0 NO 20055774 A NO20055774 A NO 20055774A NO 20055774 A NO20055774 A NO 20055774A NO 20055774 D0 NO20055774 D0 NO 20055774D0
Authority
NO
Norway
Prior art keywords
protein formulations
pharmaceutical containers
coated pharmaceutical
stabilized protein
liquid stabilized
Prior art date
Application number
NO20055774A
Other languages
English (en)
Other versions
NO20055774L (no
Inventor
Fabrizio Samaritani
Alessandra Del Rio
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055774(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20055774D0 publication Critical patent/NO20055774D0/no
Publication of NO20055774L publication Critical patent/NO20055774L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/002Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D51/00Closures not otherwise provided for
    • B65D51/005Closures provided with linings or internal coatings so as to avoid contact of the closure with the contents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO20055774A 2003-05-13 2005-12-06 Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere NO20055774L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03010671 2003-05-13
PCT/EP2004/050779 WO2004100979A2 (en) 2003-05-13 2004-05-12 Liquid stabilized protein formulations in coated pharmaceutical containers

Publications (2)

Publication Number Publication Date
NO20055774D0 true NO20055774D0 (no) 2005-12-06
NO20055774L NO20055774L (no) 2005-12-06

Family

ID=33442722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055774A NO20055774L (no) 2003-05-13 2005-12-06 Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere

Country Status (23)

Country Link
US (2) US7540382B2 (no)
EP (2) EP2324845A1 (no)
JP (2) JP2007502684A (no)
KR (1) KR101084412B1 (no)
CN (1) CN1809376B (no)
AR (1) AR044302A1 (no)
AU (1) AU2004237982C1 (no)
BR (1) BRPI0410679A (no)
CA (1) CA2523477A1 (no)
CY (1) CY1115233T1 (no)
DK (1) DK1633388T3 (no)
EA (1) EA008308B1 (no)
ES (1) ES2471942T3 (no)
HK (1) HK1088558A1 (no)
HR (1) HRP20140267T1 (no)
IL (1) IL171912A (no)
MX (1) MXPA05012191A (no)
NO (1) NO20055774L (no)
PL (1) PL1633388T3 (no)
PT (1) PT1633388E (no)
SI (1) SI1633388T1 (no)
UA (1) UA91493C2 (no)
WO (1) WO2004100979A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110466A1 (en) * 2004-05-17 2005-11-24 Ares Trading S.A. Hydrogel interferon formulations
US7731948B2 (en) * 2004-06-01 2010-06-08 Ares Trading S.A. Stabilized interferon liquid formulations
PL1845925T3 (pl) * 2005-01-12 2017-05-31 Biogen Ma Inc. Sposób podawania interferonu beta
US20070190047A1 (en) * 2005-07-29 2007-08-16 Amgen, Inc. Formulations that inhibit protein aggregation
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
KR100785070B1 (ko) 2006-07-11 2007-12-12 삼성전자주식회사 휴대 단말기에서 디지털 저작권 관리 콘텐츠 재생 방법 및장치
CA2692165A1 (en) 2007-06-25 2008-12-31 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
US9138403B2 (en) * 2007-12-20 2015-09-22 Merck Serono Sa PEG-interferon-beta formulations
BRPI0921845A2 (pt) 2008-11-12 2019-09-17 Medimmune Llc formulação aquosa estéril estável, forma de dosagem unitária farmacêutica, seringa pré-carregada, e, métodos para tratar uma doença ou distúrbio, para tratar ou prevenir rejeição, para esgotar células t que expressam icos em um paciente humano, e para interromper arquitetura central germinal em um órgão linfóide secundário de um primata
ES2765657T3 (es) 2009-12-21 2020-06-10 Hoffmann La Roche Formulación farmacéutica de bevacizumab
US8802603B2 (en) 2010-06-17 2014-08-12 Becton, Dickinson And Company Medical components having coated surfaces exhibiting low friction and low reactivity
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
FR2966044B1 (fr) * 2010-10-18 2012-11-02 Sanofi Pasteur Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
TW202012427A (zh) 2012-12-03 2020-04-01 美商諾維生物製藥有限公司 新穎縮肽及其用途
KR20150129033A (ko) 2013-03-14 2015-11-18 애브비 인코포레이티드 저 산성 종 조성물 및 이의 제조 및 사용 방법
EP2970375A1 (en) 2013-03-14 2016-01-20 AbbVie Inc. Low acidic species compositions and methods for producing the same using displacement chromatography
JP6357228B2 (ja) 2013-07-10 2018-07-11 マトリックス バイオロジー インスティテュート 高い弾性を有するヒアルロナンの組成物およびその使用
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
HUE047974T2 (hu) * 2014-03-13 2020-05-28 Stevanato Group Int A S Eljárás folyékony hatóanyag-készítmény kezelésére
US20170226552A1 (en) 2014-07-03 2017-08-10 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
WO2016007764A1 (en) 2014-07-09 2016-01-14 Abbvie Inc. Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars
WO2016144773A1 (en) 2015-03-06 2016-09-15 Abbvie Inc. Arabinosylated glycoproteins
WO2016163764A2 (ko) * 2015-04-07 2016-10-13 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
CN108135926A (zh) 2015-09-24 2018-06-08 基质生物研究所 高弹性透明质酸组合物及其使用方法
WO2017147003A1 (en) 2016-02-26 2017-08-31 Novobiotic Pharmaceuticals, Llc Novel macrocyclic antibiotics and uses thereof
FI126979B (en) 2016-02-29 2017-09-15 Faron Pharmaceuticals Oy Lyophilized pharmaceutical formulation and use thereof
US11203616B2 (en) 2017-04-04 2021-12-21 Novobiotic Pharmaceuticals, Llc Depsipeptides and uses thereof
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
EP4267210A1 (en) 2020-12-28 2023-11-01 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2622598A (en) * 1951-03-08 1952-12-23 Premo Pharmaceutical Lab Inc Drain-clear container for aqueous liquid pharmaceutical preparations
US5183746A (en) 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
JP3332379B2 (ja) 1992-05-06 2002-10-07 マリンクロッド・インコーポレイテッド 次亜塩素酸ナトリウム溶液の安定性保持用容器封鎖物システム
US5661125A (en) * 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
TW249202B (no) * 1993-08-13 1995-06-11 Ciba Gerigy Corp
JP2758154B2 (ja) 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
TR199800811T2 (xx) * 1995-11-07 1998-07-21 Genentech,Inc. NGF i�in stabilize edici form�lasyonlar.
US6142977A (en) 1996-10-18 2000-11-07 Schering Ag Prefilled, sterilized syringe with a new and improved plug
IL130524A (en) * 1996-12-24 2005-08-31 Biogen Idec Inc Stable liquid interferon formulations, a kit containing the same and a process for stabilizing the same
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
CN2326243Y (zh) 1997-09-29 1999-06-30 程继勇 覆膜药用瓶塞
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
CN2441750Y (zh) * 2000-06-23 2001-08-08 程继勇 表面覆膜药用橡胶瓶塞
JP2002209975A (ja) 2001-01-19 2002-07-30 Daikyo Seiko Ltd 医薬バイアル用ラミネートゴム栓
CN1133565C (zh) * 2001-10-18 2004-01-07 郑秀娣 药品瓶塞隔离膜

Also Published As

Publication number Publication date
IL171912A (en) 2015-02-26
KR101084412B1 (ko) 2011-11-21
PL1633388T3 (pl) 2014-08-29
ES2471942T3 (es) 2014-06-27
JP2012096063A (ja) 2012-05-24
EA008308B1 (ru) 2007-04-27
SI1633388T1 (sl) 2014-05-30
USRE43331E1 (en) 2012-05-01
HK1088558A1 (en) 2006-11-10
WO2004100979A3 (en) 2005-05-19
CA2523477A1 (en) 2004-11-25
KR20060009913A (ko) 2006-02-01
EP1633388A2 (en) 2006-03-15
AU2004237982A1 (en) 2004-11-25
UA91493C2 (uk) 2010-08-10
JP2007502684A (ja) 2007-02-15
BRPI0410679A (pt) 2006-06-20
IL171912A0 (en) 2006-04-10
US7540382B2 (en) 2009-06-02
AU2004237982C1 (en) 2018-03-08
EP1633388B1 (en) 2014-03-19
WO2004100979A2 (en) 2004-11-25
AU2004237982B2 (en) 2010-03-04
NO20055774L (no) 2005-12-06
HRP20140267T1 (hr) 2014-04-25
MXPA05012191A (es) 2006-02-08
PT1633388E (pt) 2014-06-25
EA200501692A1 (ru) 2006-06-30
CN1809376B (zh) 2010-04-28
DK1633388T3 (da) 2014-04-07
CY1115233T1 (el) 2017-01-04
CN1809376A (zh) 2006-07-26
EP2324845A1 (en) 2011-05-25
AR044302A1 (es) 2005-09-07
US20070092487A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
NO20055774D0 (no) Flytende stabiliserte proteinformuleringer i belagte farmasoytiske beholdere
DK1660104T3 (da) Farmaceutisk formulering indeholdende lanthanforbindelser
ATE550189T1 (de) Flüssigkeitsbehälter
DK1547785T3 (da) Væskebeholder
DE112004003140A5 (de) Flüssigkeitsbehälter und Flüssigkeitszuführungssystem
NO20053987L (no) Flytende farmasoytiske palonosetronformuleringer
CY2011003I1 (el) Φαρμακευτικα προϊοντα σε διαλυμα που περιεχουναντισωμα
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
ATE382261T1 (de) Flüssige formulierung
DE602004019014D1 (de) Flüssigkeitsbehälter
ITMI20020003A0 (it) Contenitore particolaremente studiato per creme cosmetiche e farmaceutiche
ITBO20050751A1 (it) Dispositivo per l'erogazione di sostanze pastose e relativi contenitori
IL170080A (en) Nucleic acid and protein known as 158p1d7 and their pharmaceutical preparations
DE60316240D1 (de) Flüssigkeitsbehälter
ITRM20020119A0 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
DE60313676D1 (de) Abgabebehälter
ATE444305T1 (de) Nmb1125-protein und dessen verwendung in pharmazeutischen formulierungen
UA9897S (uk) Ємність для рідини
ITMI20020722A1 (it) Erogatore perfezionato combinato con contenitore
UA7411S (uk) Пляшка для рідини
UA7414S (uk) Флакон для рідини
ITMI20030705A1 (it) Composizione farmaceutica contenente n-acetil-l-cisteina
SE0201660D0 (sv) Pharmaceutical formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application